Supervisory Board

The Supervisory Board is the supervisory committee of the MDC and is responsible for monitoring the legality, effectiveness, and economic efficiency of the management of all the activities of the corporation. It determines which decisions of the Board of Directors require the prior approval of the Supervisory Board and may issue instructions about important matters involving political aspects of the research and financial affairs of the corporation.

The Supervisory Board consists of no more than twelve members. Its members include, among others: two representatives from the federal government, a representative of the State of Berlin, the chairman of the Scientific Advisory Board, the Presidents of the Humboldt Universität zu Berlin and the Freie Universität Berlin, and two MDC representatives.

Chairperson

Ministerialdirektorin Bärbel Brumme-Bothe
Bundesministerium für Bildung und Forschung

Vice-Chairperson

Dr. Jutta Koch-Unterseher
Senatsverwaltung für Wirtschaft, Technologie und Forschung Berlin

Members

Dr. Jutta Koch-Unterseher
Senatsverwaltung für Wirtschaft, Technologie und Forschung Berlin

Ministerialrat Dr. Jan Grapentin
Bundesministerium für Bildung und Forschung, Berlin

Dr. Jana Wolf
Max-Delbrück-Centrum für Molekulare Medizin (MDC) Berlin-Buch

Prof. Dr. Peter-André Alt
FU Berlin

Prof. Dr. Claus Scheidereit
MDC

Prof. Dr. Andreas Busch
Bayer Pharmaceuticals

Prof. Dr. Annette Grüters-Kieslich
Charité

Prof. Dr. Sabine Kunst
HU Berlin

Prof. Dr. Horst Domdey
BioM GmbH

Prof. Dr. Hannah Monyer
DKFZ

Ministerialdirektorin Bärbel Brumme-Bothe
Bundesministerium für Bildung und Forschung